Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Feb. 01, 2025	Feb. 03, 2024
Cash flows from operating activities:
Net income	$ 1,980,422	$ 2,338,437
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	42,576	39,255
Undistributed earnings in joint venture - Majestic 21	(25,805)	(22,174)
Return on investment in joint venture-Majestic 21	0	1,600,889
Increase (decrease) in fair market value of equity investments	2,916	(50,799)
Stock-based compensation	40,254	33,220
Decrease (increase) in:
Accounts receivable - trade	1,013,502	595,448
Inventories	765,079	1,456,452
Prepaid expenses and other current assets	37,509	70,948
Interest receivable	(146,066)	(137,759)
(Decrease) increase in:
Accounts payable	14,974	(134,981)
Accrued compensation	(176,179)	(13,757)
Accrued expenses and other current liabilities	(322,625)	(35,013)
Income taxes payable	(76,210)	110,092
Customer deposits	(732,481)	(3,050,498)
Net cash provided by operating activities	2,417,866	2,799,760
Cash flows from investing activities:
Purchase of property, plant and equipment	(117,198)	(122,444)
Purchase certificates of deposit	(1,500,000)	(2,882,000)
Proceeds from certificates of deposit	1,920,000	1,434,000
Collections on interest receivable	99,644	77,339
Collections on mortgage notes receivable	476	45
Increase in cash surrender value of life insurance	(51,000)	(44,025)
Net cash provided by (used in) investing activities	351,922	(1,537,085)
Increase in cash and cash equivalents	2,769,788	1,262,675
Cash and cash equivalents at beginning of period	13,521,296	13,879,358
Cash and cash equivalents at end of period	16,291,084	15,142,033
Supplemental financing activity:
Income taxes paid	$ 745,000	$ 675,000